We have now written 5 articles for the IPKat blog. We are very appreciative of the opportunity to write for this prestigious blog. These are the articles:
This was about whether the European Patent Office was about to change its policy on the way it looks at the feature of patient groups when assessing the novelty of medical use claims. That would clearly have a lot of implications for claims covering personalised medicine inventions.
This article discussed what contributes to innovation and how it is measured, together with thoughts on how innovation policies fit into the wider issues of how a country should decide on where to use its resources.
This article explores the debate around the issue of access to medicines in the developing world, and whether this is a human rights issue.
This article reviewed the UK Court decision AGA Medical v Occlutech and contrasted the findings of the UK judge with what happened at opposition at the European Patent Office.
This is about proposals from the UK IPO to change the way it publishes application. The article considers all the possible consequences of this seemingly mundane issue.
We have also had the following articles published on blogs related to IPKat:
Are We Too Afraid to Rethink the Patent System (on the PatLit blog)
This article explores whether the patent system is still fit for purpose in the age of open innovation ecosystems.
Ethics Versus Money in University Tech Transfer (on the IP Finance blog)
This article considers whether hard-pressed university tech transfer offices should turn to Patent Assertion Entities to monetise their patents.